BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Increase in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 4,700 shares, a growth of 6.8% from the December 15th total of 4,400 shares. Based on an average trading volume of 6,700 shares, the short-interest ratio is currently 0.7 days.

BioNxt Solutions Price Performance

BNXTF stock opened at $0.25 on Tuesday. The stock has a market cap of $28.52 million, a PE ratio of -6.29 and a beta of 0.67. The firm’s 50-day simple moving average is $0.23 and its 200 day simple moving average is $0.20. BioNxt Solutions has a fifty-two week low of $0.11 and a fifty-two week high of $0.53.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.